Traverso Chambers Private Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Traverso Chambers Private Wealth Management's PFE Position: Q4 2023 in Review
Traverso Chambers Private Wealth Management increased its Pfizer (PFE) stake by 1.8% in Q4 2023, buying an estimated $17.8K and bringing the position to 32,618 shares worth $939K. The position accounts for 0.23% of the portfolio, ranked #58.
Traverso Chambers Private Wealth Management first reported a position in PFE in Q4 2018 and has held it in 21 quarters since. The position peaked at $1.8M in Q4 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.
- Traverso Chambers Private Wealth Management held 32,618 shares of Pfizer worth $939K as of Q4 2023.
- Traverso Chambers Private Wealth Management bought 589 Pfizer shares in Q4 2023, an estimated $17.8K.
- Pfizer made up 0.23% of Traverso Chambers Private Wealth Management's portfolio in Q4 2023, its #58 holding.
- Traverso Chambers Private Wealth Management first reported a position in Pfizer in Q4 2018 and has held it in 21 quarters since.
- Traverso Chambers Private Wealth Management's Pfizer position peaked at $1.8M in Q4 2021.
- 2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.
Based on Traverso Chambers Private Wealth Management's 13F filing for Q4 2023, filed 9 Jan 2024.